{"id":"https://openalex.org/W2761513235","doi":"https://doi.org/10.1093/eurheartj/ehx504.p4368","title":"P4368Characteristics and treatment of worsening chronic heart failure: real world evidence from linked PINNACLE Registry and claims data","display_name":"P4368Characteristics and treatment of worsening chronic heart failure: real world evidence from linked PINNACLE Registry and claims data","publication_year":2017,"publication_date":"2017-08-01","ids":{"openalex":"https://openalex.org/W2761513235","doi":"https://doi.org/10.1093/eurheartj/ehx504.p4368","mag":"2761513235"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehx504.p4368","doi":"https://doi.org/10.1093/eurheartj/ehx504.p4368","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehx504.p4368","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022314919","display_name":"Javed Butler","orcid":"https://orcid.org/0000-0001-7683-4720","observed_orcids":["https://orcid.org/0000-0001-7683-4720","https://orcid.org/0000-0003-4267-6933"]},"institutions":[{"id":"https://openalex.org/I2801410363","display_name":"Stony Brook University Hospital","ror":"https://ror.org/05wyq9e07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801410363","https://openalex.org/I4210102711","https://openalex.org/I59553526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Butler","raw_affiliation_strings":["Stony Brook University Medical Center, Cardiology Division, Stony Brook, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stony Brook University Medical Center, Cardiology Division, Stony Brook, United States of America","institution_ids":["https://openalex.org/I2801410363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070927851","display_name":"Edgar Fern\u00e1ndez Fonseca","orcid":"https://orcid.org/0000-0002-6685-0441","observed_orcids":["https://orcid.org/0000-0002-6685-0441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Fonseca","raw_affiliation_strings":["Symphony Health Solutions, Scientific Studies & Projects, Conshohocken, United States of America","Scientific Studies & Projects, Conshohocken, United States of America;","Symphony Health Solutions,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Symphony Health Solutions, Scientific Studies & Projects, Conshohocken, United States of America","institution_ids":[]},{"raw_affiliation_string":"Scientific Studies & Projects, Conshohocken, United States of America;","institution_ids":[]},{"raw_affiliation_string":"Symphony Health Solutions,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080164893","display_name":"Mei Yang","orcid":"https://orcid.org/0009-0002-5795-5054","observed_orcids":["https://orcid.org/0009-0002-5795-5054"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Yang","raw_affiliation_strings":["Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, United States of America","Merck Sharp & Dohme Corp.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, United States of America","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp & Dohme Corp.,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113094378","display_name":"T. Rhodes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Rhodes","raw_affiliation_strings":["Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, United States of America","Merck Sharp & Dohme Corp.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, United States of America","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp & Dohme Corp.,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108190025","display_name":"Mahesh J. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.J. Patel","raw_affiliation_strings":["Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, United States of America","Merck Sharp & Dohme Corp.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, United States of America","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp & Dohme Corp.,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028816705","display_name":"Massimiliano Alfonzo Manzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Manzi","raw_affiliation_strings":["Symphony Health Solutions, Scientific Studies & Projects, Conshohocken, United States of America","Scientific Studies & Projects, Conshohocken, United States of America;","Symphony Health Solutions,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Symphony Health Solutions, Scientific Studies & Projects, Conshohocken, United States of America","institution_ids":[]},{"raw_affiliation_string":"Scientific Studies & Projects, Conshohocken, United States of America;","institution_ids":[]},{"raw_affiliation_string":"Symphony Health Solutions,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031418293","display_name":"G.P. Hess","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.P. Hess","raw_affiliation_strings":["Symphony Health Solutions, Scientific Studies & Projects, Conshohocken, United States of America","Scientific Studies & Projects, Conshohocken, United States of America;","Symphony Health Solutions,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Symphony Health Solutions, Scientific Studies & Projects, Conshohocken, United States of America","institution_ids":[]},{"raw_affiliation_string":"Scientific Studies & Projects, Conshohocken, United States of America;","institution_ids":[]},{"raw_affiliation_string":"Symphony Health Solutions,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088310205","display_name":"Michael M. Givertz","orcid":"https://orcid.org/0000-0003-1012-7710","observed_orcids":["https://orcid.org/0000-0003-1012-7710"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.M. Givertz","raw_affiliation_strings":["Brigham and Women's Hospital, Cardiovascular Division, Boston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Cardiovascular Division, Boston, United States of America","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22853415,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heart-failure-with-reduced-ejection-fraction","display_name":"heart failure with reduced ejection fraction","score":0.9919999837875366},{"id":"https://openalex.org/keywords/guideline-directed-therapy","display_name":"guideline-directed therapy","score":0.6110000014305115},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.6119999885559082},{"id":"https://openalex.org/keywords/intravenous-diuretics","display_name":"intravenous diuretics","score":0.9259999990463257},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.6940000057220459},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9760000109672546},{"id":"https://openalex.org/keywords/angiotensin-receptor-neprilysin-inhibitors","display_name":"angiotensin receptor-neprilysin inhibitors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9449999928474426},{"id":"https://openalex.org/keywords/ivabradine","display_name":"ivabradine","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mineralocorticoid-receptor-antagonists","display_name":"mineralocorticoid receptor antagonists","score":1.0},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.5540000200271606},{"id":"https://openalex.org/keywords/pinnacle-registry","display_name":"PINNACLE registry","score":0.9309999942779541}],"concepts":[{"id":"https://openalex.org/C2776017024","wikidata":"https://www.wikidata.org/wiki/Q683031","display_name":"Pinnacle","level":4,"score":0.9800646305084229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9713610410690308},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5312240719795227},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.40512096881866455},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.386145681142807},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3428940176963806},{"id":"https://openalex.org/C201645570","wikidata":"https://www.wikidata.org/wiki/Q830637","display_name":"Radiation treatment planning","level":3,"score":0.07726573944091797},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/eurheartj/ehx504.p4368","doi":"https://doi.org/10.1093/eurheartj/ehx504.p4368","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehx504.p4368","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899276331","https://openalex.org/W2915620466","https://openalex.org/W3011179286","https://openalex.org/W3011440694","https://openalex.org/W3047295367","https://openalex.org/W4394953369","https://openalex.org/W4388460977","https://openalex.org/W1980358828","https://openalex.org/W3159945411","https://openalex.org/W4380795314"],"abstract_inverted_index":{"Background:":[0],"Heart":[1],"Failure":[2],"(HF)":[3],"impacts":[4],"6.5":[5],"million":[6,10],"Americans":[7],"and":[8,33,51,95,98,106,123,193,196],"40":[9],"people":[11],"worldwide,":[12],"with":[13,19,65,88,96,117,147],"50%":[14],"estimated":[15],"to":[16,79,84],"have":[17],"HF":[18,36,119,149,154,156],"reduced":[20],"ejection":[21,91],"fraction":[22,92],"(HFrEF).":[23],"Despite":[24],"guideline-directed":[25],"therapy,":[26],"these":[27],"patients":[28,55,64,146],"may":[29],"develop":[30],"progressive":[31],"symptoms":[32],"worsening":[34],"chronic":[35,140,148],"(WCHF)":[37],"that":[38],"require":[39],"escalated":[40],"treatment":[41],"(RX)":[42],"including":[43],"hospitalisation.":[44,155],"Purpose:":[45],"This":[46],"study":[47],"assessed":[48],"the":[49,69,159],"characteristics":[50],"RX":[52,157],"patterns":[53],"of":[54,62,190],"who":[56],"developed":[57],"WCHF.":[58],"Methods:":[59],"Medical":[60],"records":[61],"U.S.":[63],"incident":[66],"HFrEF":[67,191],"from":[68,81],"PINNACLE":[70],"Registry":[71],"(a":[72],"National":[73],"Cardiovascular":[74],"Data":[75],"Registry)":[76],"were":[77,114,136],"linked":[78],"claims":[80,100],"Jan":[82],"2011":[83],"Jun":[85],"2016.":[86],"Patients":[87],"left":[89],"ventricular":[90],"(LVEF)":[93],"\u226445%":[94],"pharmacy":[97],"medical":[99],"in":[101,107],"a":[102,124],"6-month":[103],"baseline":[104],"period":[105,126],"\u22651-year":[108],"follow-up":[109],"or":[110,132,153,184],"mortality":[111],"within":[112,187,200],"1-year":[113],"included.":[115],"Those":[116],"stable":[118],"therapy":[120],"\u226530":[121],"days":[122,189],"90-day":[125],"without":[127],"HF-related":[128],"hospitalisations,":[129],"emergency":[130],"visits,":[131],"IV":[133,151],"diuretic":[134,152],"use":[135],"identified":[137],"as":[138],"having":[139],"HF.":[141],"WCHF":[142,194],"was":[143],"defined":[144],"when":[145],"required":[150],"included":[158],"first":[160],"prescription":[161],"for":[162],"an":[163],"angiotensin-converting":[164],"enzyme":[165],"inhibitor":[166],"(ACEi),":[167],"angiotensin":[168,172],"receptor":[169,173,181],"blocker":[170,177],"(ARB),":[171],"neprilysin":[174],"inhibitor,":[175],"beta":[176],"(BB),":[178],"ivabradine,":[179],"mineralocorticoid":[180],"antagonist":[182],"(MRA),":[183],"hydralazine/isosorbide":[185],"dinitrate":[186],"180":[188],"diagnosis":[192],"onset":[195],"other":[197],"therapies":[198],"dispensed":[199],"45":[201],"days.":[202]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-10-20T00:00:00"}